79P Molecular targeted therapy for Her2 positive breast cancer in private sector: Yangon experience. (20th December 2016) - Khine, M.; Mon, S.; Sein, N.; Aye, T.T.; Htay, S.S.; Kyaw, N.H.; Aung, E.P.P.; Hnin, P.T.